Microbe L. lactis shows promise for ameliorating colitis

In published in the Proceedings of the National Academy of Sciences, researcher Wendy Garrett, of Harvard T.H. Chan School of Public Health and the Ó³»­´«Ã½, and colleagues identified a strain of bacteria with the potential to abate gut inflammation. They found that Lactococcus lactis, used in the manufacture of dairy products, naturally releases an antioxidant known as superoxide dismutase A (SodA) — but only if ruptured by a specific, bacteria-attacking enzyme. This chain of events helps to correct an imbalance of chemically reactive molecules within the body associated with gut inflammation. These findings suggest a possible treatment avenue for inflammatory bowel disease and other colon-related ailments.